Vaccines against human cytomegalovirus: time to test.
Infections associated with human cytomegalovirus are an important cause of morbidity and mortality in immunocompromised individuals. Recent studies in humans and animal models have shown that some human cytomegalovirus proteins can induce protective immunity. The availability of recombinant viral proteins means that candidate subunit vaccines can now be tested in clinical trials.
Britt
W J
WJ
Dept of Pediatrics, University of Alabama at Birmingham 35233, USA. pedp034@uabdpo.dpo.uab.edu
D000818:Animals; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D013997:Time Factors; D014765:Viral Vaccines / Q000276:immunology*
D014765:Viral Vaccines